Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study (Q39170630)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 2016
edit
Language Label Description Also known as
English
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
scientific article published on August 2016

    Statements

    Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study (English)
    Maud Lemoine
    Yusuke Shimakawa
    Ramou Njie
    Makie Taal
    Isabelle Chemin
    Sumantra Ghosh
    Harr F Njai
    Adam Jeng
    Penda Suso
    Saydiba Tamba
    Abdullah Jatta
    Louise Sarr
    Aboubacar Kambi
    William Stanger
    Jessica Howell
    Liliane Mpabanzi
    Ousman Nyan
    Maimuna Mendy
    Mark R Thursz
    PROLIFICA investigators
    1 August 2016
    e559-67

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit